A 52-year-old man with benign prostatic hyperplasia (BPH) and hypertension presents with nocturia and weak urinary stream. He requires a drug that selectively blocks α1A-adrenergic receptors in the prostate smooth muscle while minimizing cardiovascular side effects. Which of the following is the drug of choice?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.